✦ LIBER ✦

Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia

✍ Scribed by David Marin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can We and Should We Improve on Frontlin

✍ Carmen Fava; Giuseppe Saglio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Treatment modalities in hematology: Imat

✍ A. Gratwohl 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 212 KB

Nilotinib as frontline and second-line t

✍ Peter Valent; Günther Gastl; Klaus Geissler; Richard Greil; Oliver Hantschel; Al 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Current status and perspectives of thera

✍ Wolfgang Hiddemann; Thomas Büchner 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 592 KB

Reduction of immunoglobulin levels durin

✍ Giulia Cervetti; Giovanni Carulli; Sara Galimberti; Antonio Azzarà; Elisa Canniz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Μultiple myeloma developing after imatin

✍ A. Galanopoulos; S. I. Papadhimitriou; E. Kritikou-Griva; M. Georgiakaki; N. I. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 56 KB